Jeffrey Vietri

11PUBLICATIONS
33CO-AUTHORS
Pacific Peoples social determinants of healthEpidemiological modellingPanel data analysisHealth promotionPacific Peoples health policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 28, 2026
Socioeconomic value of adult respiratory vaccination in the United States: a benefit-cost analysis.

|Jul 16, 2026
Clinical and Economic Burden of Pneumococcal Disease Due to Serotypes Contained in the 20-Valent Pneumococcal Conjugate Vaccine in the Adult Population in France.

|Jan 21, 2026
Cost-effectiveness and return on investment of 20-valent pneumococcal conjugate vaccine use among adults in England: analysis from the societal perspective.

Diana Mendes, Ahuva Averin, Mark Atwood

|Sep 25, 2025
The incremental net monetary benefit of higher-valent pneumococcal conjugate vaccines for adults: a systematic review and meta-analysis of economic evaluations.

Haeseon Lee, Jeong-Yeon Cho, Jeffrey Vietri

|Jun 13, 2025
Health and economic impact of 20-valent pneumococcal conjugate vaccine for adults aged 66-84 years in Japan and Shiga prefecture.

Tomoyuki Suzuki, Yoko Hirano, Kazumasa Kamei

|May 04, 2024
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan.

Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu

Pageof 2

Frequent Collaborators

2 joint publications

Diana Mendes

2 joint publications

Kazumasa Kamei

1 joint publications

Masayo Sato

1 joint publications

Jens Olsen